Consider a case where a patient has a disease with high mortality and no effective treatment available. A new experimental drug is now being tested in a clinical trial. However, this is a randomized clinical trial, which means that it will have a treatment group and a placebo group (that does not get the actual drug).
Related Articles

Featured
The Face of Biotech is Changing: Summary of the #SDBNJune Event
June 27, 2014
Leah Cannon
Featured, SDBN Blog
Comments Off on The Face of Biotech is Changing: Summary of the #SDBNJune Event
Old funding and research methods are no longer working for small biotechs, big pharma or academic scientists. The flip side of this crisis is breeding innovation at every stage of the drug discovery pipeline. As […]

SDBN Blog
Bioethics of Compassionate Use of Drugs: BIO2014
June 24, 2014
Sandeep Pingle
SDBN Blog
Comments Off on Bioethics of Compassionate Use of Drugs: BIO2014
BIO2014 begins! The much-awaited 2014 BIO International Convention kicked off with a day of special sessions on Monday, June 23rd, 2014. via Bioethics of Compassionate Use of Drugs: BIO2014.

Uncategorized
BIO 2014: Why San Diego is a Hub for RNA R&D and Drug Development | Xconomy
June 23, 2014
Mary Canady
Uncategorized
Comments Off on BIO 2014: Why San Diego is a Hub for RNA R&D and Drug Development | Xconomy
BIO 2014: Why San Diego is a Hub for RNA R&D and Drug Development | Xconomy.